BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18482923)

  • 1. Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system.
    Cauliez B; Guignery J; Marinier S; Mariau I; Lavoinne A
    Ann Clin Biochem; 2008 May; 45(Pt 3):318-9. PubMed ID: 18482923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
    Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
    Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)].
    Benoit MO; Dautezac F; Taccoen M; Paul JL
    Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sample handling on serum N-terminal proB-type natriuretic peptide concentration in normal dogs and dogs with heart disease.
    Collins SA; Patteson MW; Connolly DJ; Brodbelt DC; Torrance AG; Harris JD
    J Vet Cardiol; 2010 Apr; 12(1):41-8. PubMed ID: 20226751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NT-proBNP measurement on Immulite 2500 (DPC): analytical performance and comparison with Roche Diagnostics and Dade-Behring NT-proBNP immunoassays].
    Cauliez B; Boucher S; Duflo-Leroy A; Lavoinne A
    Ann Biol Clin (Paris); 2007; 65(1):93-8. PubMed ID: 17264046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP.
    Chien TI; Chen HH; Kao JT
    Clin Chim Acta; 2006 Jul; 369(1):95-9. PubMed ID: 16515777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples.
    Mueller T; Gegenhuber A; Dieplinger B; Poelz W; Haltmayer M
    Clin Chem Lab Med; 2004; 42(8):942-4. PubMed ID: 15387447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction.
    Downie PF; Talwar S; Squire IB; Davies JE; Barnett DB; Ng LL
    Clin Sci (Lond); 1999 Sep; 97(3):255-8. PubMed ID: 10464049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
    Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The N-terminal pro-brain natriuretic peptide (NT-proBNP) assay with the Stratus CS analyzer].
    Chenevier-Gobeaux C; Guillot D; Ursulet J; Paul JL; Ekindjian OG; Desmoulins D; Benoit MO
    Ann Biol Clin (Paris); 2007; 65(1):77-82. PubMed ID: 17264043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
    Masson S; Latini R; Anand IS; Barlera S; Angelici L; Vago T; Tognoni G; Cohn JN;
    J Am Coll Cardiol; 2008 Sep; 52(12):997-1003. PubMed ID: 18786480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly variability of plasma and serum NT-proBNP measurements in normal dogs.
    Kellihan HB; Oyama MA; Reynolds CA; Stepien RL
    J Vet Cardiol; 2009 May; 11 Suppl 1():S93-7. PubMed ID: 19395335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and calibration of a new point-of-care test for the determination of NT-proBNP in whole blood.
    Bertsch T; Dikkeschei B; Gurr E; Hayen W; Jørgensen B; Lotz J; Müller-Bardorff M; Ordóñez-Llanos J; Schulz I; Spinke J; Thiele M; Zerback R
    Clin Lab; 2007; 53(7-8):423-31. PubMed ID: 17821946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.